|Day Low/High||84.84 / 85.83|
|52 Wk Low/High||55.36 / 90.61|
While both companies appear like winners, WBA should have more to gain because of its discounted price.
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
The upcoming quarterly report for WBA might be a market mover, but the charts and indicators of CVS show a healthy stock ready to rise.
What I suggest individual investors do is give their portfolios a physical. Like a visit to the doctor.
Let's review 2019 performance of RMPIA in relation to stock indexes and see what's ahead.
This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.
It seemed to happen overnight. People watched. People listened. People cared. About what? Individual stocks.
Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.
There is no doubt in my mind that the firm is executing at a high level.
Now, many Real Money Post Industrial Average stocks should see a boost from the holiday splurge by shoppers.
I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.
I like the name, and I like the progress that CVS is making. This stock can go higher.
Even before reporting better-than-expected third-quarter results, the pharmacy giant was seeing more aggressive buying of its shares.
OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.
Disney, Qualcomm and Square are among 75 key reports we are watching.
Charts and indicators agree with Jim Cramer's bullish year-end call.
There are plenty of senior growth companies that can still move higher.
RMPIA is up 20.9% in the first nine months of 2019.
When you have an oversold market you've got a true coiled spring that can rally beyond where it might ordinary go on good news.
So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.
The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.
Following its Aetna acquisition that closed back in November, CVS is positioning itself for further strength.
CVS continues to move in the right direction for the bulls.
Gains in Amgen, CVS, and others helped offset declines in other stocks, as the RMPIA rose over the last two months to 0.6%, handily beating all the major domestic stock market averages.
Agency has the authority to carve out an exception to existing laws.
LYFT's earnings beat appears to be giving hope to Uber investors in advance of its own report later Thursday, but the two rivals have key strengths to watch, such as Lyft's U.S. focus and Uber's move on food delivery.
Lower rates are terrible unless you spend money, buy goods, create businesses, refinance loans and basically exist in America.
The Chinese government has now demonstrated an ability to control the S&P 500, even at the risk of Chinese domestic capital flight.